Altasciences has named Peter Varney, pharma development strategy advisor, and Hazel Clay, who will be charged with supporting the development of innovator pharmaceutical assets. Varney has more than 40 years of experience in commercial development, strategic alliances, and relationship management at Covance, while Clay has more than 30 years of experience in supporting the development of innovator pharmaceutical assets at Covance, where she will play a key role as drug development advisor in ...